Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer
Clinical trial NCT03608046 · UNKNOWN
Trial details
- NCT number
- NCT03608046
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-03
- Primary completion
- 2023-12-31
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.